C‑section, formula may disrupt ‘good’ gut bacteria in babies

Abstract

Early intestinal colonization with Lactobacilli and Bifidobacteria support the concept of their ability to modify the gut microbiota with beneficial roles like reduction in the risk of cancer due to their capacity to decrease β‑glucoronidase and carcinogen levels. Thus, these agents (referred to as “probiotics”) are being tried to be employed in modern nutrition habits (with so‑called functional foods). Since they are normal residents of the microbiota in humans, whether such gut derived probiotic should be commercially employed is a matter of debate

Keywords: News and Views